E-ISSN 2636-834X
 
2024, Vol: 14, Issue: 1
14 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM
_Title_Page_Obligatory_(v2r)_

Case Report 


Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report

Cilem Bilginer.


Abstract
Angioedema is a rare but life-threatening condition characterized by swelling in subcutaneous tissues and mucosa. Paliperidone is an effective treatment option for treatment-resistant patients with depression. While the most common adverse effect caused by medication is headaches, it is also less likely to observe edema or anaphylactic reaction. In this case report, an adolescent diagnosed with major depression and suffered from angioedema following oral paliperidone augmentation during the treatment was presented. Edema regressed spontaneously about 24-30 hours following the last drug intake. No significant laboratory finding that could explain this condition was found. The patient no longer suffered from a similar problem following discontinuation of paliperidone. This case suggests that the clinician should be alerted against possible allergic reactions by reason of oral usage of paliperidone in adolescents and further studies are needed to explore the underlying mechanisms of allergic responses for these patients.

Key words: paliperidone, risperidone, angioedema, adolescent


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Cilem Bilginer
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. 2017; 7(2): 128-30. doi:10.5455/jmood.20170404040638

Web Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. https://www.pbsciences.org/?mno=258736 [Access: April 08, 2024]. doi:10.5455/jmood.20170404040638

AMA (American Medical Association) Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. 2017; 7(2): 128-30. doi:10.5455/jmood.20170404040638


Vancouver/ICMJE Style

Cilem Bilginer. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS. (2017), [cited April 08, 2024]; 7(2): 128-30. doi:10.5455/jmood.20170404040638


Harvard Style

Cilem Bilginer (2017) Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. PBS, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Turabian Style

Cilem Bilginer. 2017. Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. Psychiatry and Behavioral Sciences, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Chicago Style

Cilem Bilginer. "Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report." Psychiatry and Behavioral Sciences 7 (2017), 128-30. doi:10.5455/jmood.20170404040638


MLA (The Modern Language Association) Style

Cilem Bilginer. "Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report." Psychiatry and Behavioral Sciences 7.2 (2017), 128-30. Print. doi:10.5455/jmood.20170404040638


APA (American Psychological Association) Style

Cilem Bilginer (2017) Angioedema caused by oral paliperidone augmentation in the major depressive disorder treatment: a case report. Psychiatry and Behavioral Sciences, 7 (2), 128-30. doi:10.5455/jmood.20170404040638


Author LoginReviewer Login

About Psychiatry and Behavioral Sciences

Psychiatry and Behavioral Sciences is a scientific journal currently published by Turkish Association for Psychopharmacology.  It has been published as ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Editor in Chief

Prof. Dr. Mesut ÇETİN
Address: Bagdat Cad. Birgen Is Merkezi 226/7 Kadikoy - Istanbul - TURKEY 34728Phone:+90 (532) 272 32 52E-mail:psikofarmakoloji@gmail.com